The wave of giant pharmaceuticals deals might not be over just yet.

AbbVie stunned investors last month by agreeing to acquire Allergan for $63 billion. Earlier this year, Bristol-Myers Squibb announced that it would purchase Celgene for $74 billion, while Japanese drug giant Takeda Pharmaceutical purchased Shire for $58 billion last year.

...